Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 3,820 | 3,317 | 6,339 | 24,036 | 68,805 |
| Gross Profit | 3,820 | 3,317 | 6,339 | 24,036 | 68,805 |
| Operating Expenses | 33,374 | 30,652 | 37,063 | 35,578 | 47,173 |
| Operating Income | -29,554 | -27,335 | -30,724 | -11,542 | 21,632 |
| Interest Expense | 178 | 42 | 53 | 55 | 24 |
| Other Income | -1,303 | -791 | 8,487 | 318 | 48 |
| Pre-tax Income | -31,035 | -28,168 | -22,290 | -11,279 | 21,656 |
| Net Income Continuous | -31,035 | -28,168 | -22,290 | -11,279 | 21,656 |
| Net Income | $-31,035 | $-28,168 | $-22,290 | $-11,279 | $21,656 |
| EPS Basic Total Ops | -13.81 | -13.81 | -11.41 | -5.71 | 11.41 |
| EPS Basic Continuous Ops | -13.71 | -13.86 | -11.33 | -5.68 | 11.26 |
| EPS Diluted Total Ops | -13.81 | -13.81 | -10.81 | -5.71 | 10.81 |
| EPS Diluted Continuous Ops | -13.71 | -13.86 | -10.94 | -5.68 | 10.87 |
| EBITDA(a) | $-27,416 | $-25,166 | $-28,243 | $-8,969 | $24,296 |